Characteristics of 20 Patients Who Showed Conversion to PCR+ and Subsequent Hematologic Relapse
| Patient No. . | Age/Sex . | PML Break Type . | Maintenance . | First Molecular CR Duration (mo)-150 . | Time From PCR+ to Hematologic Relapse (mo) . |
|---|---|---|---|---|---|
| 1. | 53/F | L | None | 3 | 3 |
| 2. | 36/F | S | None | 3 | 6 |
| 3. | 38/M | L | CHT-151 | 5 | 3 |
| 4. | 35/F | S | CHT + ATRA | 5 | 2 |
| 5. | 43/M | L | None | 4 | 2 |
| 6. | 54/M | L | CHT + ATRA | 2 | 14 |
| 7. | 44/M | S | CHT + ATRA | 8 | 9 |
| 8. | 43/M | L | ATRA | 5 | 1 |
| 9. | 25/M | S | None | 3 | 1 |
| 10. | 35/M | S | CHT + ATRA | 3 | 4 |
| 11. | 62/M | L | CHT | 10 | 4 |
| 12. | 20/M | L | None | 1 | 4 |
| 13. | 10/M | L | CHT | 9 | 2 |
| 14. | 26/F | L | CHT | 4 | 3 |
| 15. | 46/F | S | ATRA | 9 | 8 |
| 16. | 29/M | L | ATRA | 2 | 3 |
| 17. | 13/M | L | ATRA | 4 | 1 |
| 18. | 13/F | L | None | 5 | 3 |
| 19. | 44/F | S | None | 4 | 1 |
| 20. | 37/M | S | None | 4 | 1 |
| Patient No. . | Age/Sex . | PML Break Type . | Maintenance . | First Molecular CR Duration (mo)-150 . | Time From PCR+ to Hematologic Relapse (mo) . |
|---|---|---|---|---|---|
| 1. | 53/F | L | None | 3 | 3 |
| 2. | 36/F | S | None | 3 | 6 |
| 3. | 38/M | L | CHT-151 | 5 | 3 |
| 4. | 35/F | S | CHT + ATRA | 5 | 2 |
| 5. | 43/M | L | None | 4 | 2 |
| 6. | 54/M | L | CHT + ATRA | 2 | 14 |
| 7. | 44/M | S | CHT + ATRA | 8 | 9 |
| 8. | 43/M | L | ATRA | 5 | 1 |
| 9. | 25/M | S | None | 3 | 1 |
| 10. | 35/M | S | CHT + ATRA | 3 | 4 |
| 11. | 62/M | L | CHT | 10 | 4 |
| 12. | 20/M | L | None | 1 | 4 |
| 13. | 10/M | L | CHT | 9 | 2 |
| 14. | 26/F | L | CHT | 4 | 3 |
| 15. | 46/F | S | ATRA | 9 | 8 |
| 16. | 29/M | L | ATRA | 2 | 3 |
| 17. | 13/M | L | ATRA | 4 | 1 |
| 18. | 13/F | L | None | 5 | 3 |
| 19. | 44/F | S | None | 4 | 1 |
| 20. | 37/M | S | None | 4 | 1 |